Entero Therapeutics
Why Robinhood?
You can watch ENTO and buy or sell other stocks, ETFs, and their options commission-free!About ENTO
GridAI Technologies Corp. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide.
ENTO Key Statistics
Stock Snapshot
With a market cap of 12.18M, Entero Therapeutics(ENTO) trades at $4.78. The stock has a price-to-earnings ratio of -0.20.
On 2026-04-01, Entero Therapeutics(ENTO) stock opened at —, reached a high of —, and a low of —.
Entero Therapeutics(ENTO) shares are trading with a volume of 0, against a daily average of 51.94K.
In the last year, Entero Therapeutics(ENTO) shares hit a 52-week high of $5.84 and a 52-week low of $0.97.
In the last year, Entero Therapeutics(ENTO) shares hit a 52-week high of $5.84 and a 52-week low of $0.97.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.